In a neuronal tauopathy mouse model, depletion of senescent microglia effectively reduced tau pathology and significantly improved cognitive function [123], directly confirming the critical driver role of microglial senescence in AD progression [124]. The gene discussed is MAPT; the disease is Alzheimer disease.